JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK-STAT Signaling Pathway. This evidence concerns the gene JPH3 and thyroid gland undifferentiated (anaplastic) carcinoma.